PURPOSE: To analyse anatomoclinic and evolutive aspects of @entity775 ( @entity775 ) through 50 observations collected in two Internal Medicine departments in Algiers from 1998 to 2002 and to make a review of the literature. METHODS: The study is prospective. The diagnosis of @entity775 ( @entity775 ) is established according to the recommendations of the score of the International @entity775 Group (1991) or/and @entity16 confirmed by histology. RESULTS: Fifty @entity1 were studied: (32 @entity1 -18 @entity1 ) and the mean age was 38 years (17 to 73). @entity792 were associated in 26%. The @entity775 type 1 has been noted in 58%. @entity775 were type 2 in only 6%. In 22% of the cases @entity775 were sero-negative and the others @entity775 represented 14% were classed as @entity3928 (5 cases of @entity2835 and 2 cases of @entity991 @entity99 @entity3928 ). The first liver biopsy tissue showed strong necrotic-inflammatory activity in 56% and @entity82 was identified in 19 @entity1 (38%). The treatment ( @entity500 and @entity228 ) was prescribed in 37 @entity1 (74%) in active chronic @entity99 or in compensed @entity82 . FOLLOW-UP: 28% of the @entity1 died (9-36 months) because @entity82 or because complications of hepatocarcinoma (3 cases). CONCLUSION: The diagnosis of @entity775 must be established early for each @entity1 with chronic @entity409 particularly is those are supposed as a crypto genetic @entity99 . The prognosis is compromised by delayed diagnosis and the mortality in middle following up is high.

[Autoimmune chronic active hepatitis: anatomoclinic's study of 50 XXXX ].

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient', 'men'] @entity2835 :: ('MESH:D008105', 'Disease') :: ['primary biliary cirrhosis'] @entity82 :: ('MESH:D005355', 'Disease') :: ['cirrhosis', "cirrhosis's complications"] @entity500 :: ('MESH:D001379', 'Chemical') :: ['azathioprine'] @entity3928 :: ('MESH:C536030', 'Disease') :: ['overlap syndrome', 'overlap-syndrome'] @entity16 :: ('MESH:D009422', 'Disease') :: ['hepatitic damage'] @entity991 :: ('MESH:D015209', 'Disease') :: ['primary sclerosing cholangitis'] @entity228 :: ('CHEBI:50858', 'Chemical') :: ['corticosteroid'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver disease'] @entity99 :: ('MESH:D056486', 'Disease') :: ['hepatitis'] @entity792 :: ('MESH:D001327', 'Disease') :: ['Autoimmune extra-hepatitic manifestations'] @entity775 :: ('MESH:D019693', 'Disease') :: ['AIH', 'autoimmune hepatitis', 'Autoimmune Hepatitis']
@entity1 :: (9606,Species) :: ['patients']
